Susan Zhou

740 total citations
28 papers, 581 citations indexed

About

Susan Zhou is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Virology. According to data from OpenAlex, Susan Zhou has authored 28 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Virology. Recurrent topics in Susan Zhou's work include Diabetes Treatment and Management (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (7 papers). Susan Zhou is often cited by papers focused on Diabetes Treatment and Management (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (7 papers). Susan Zhou collaborates with scholars based in United States, France and China. Susan Zhou's co-authors include Vaishali Sahasrabudhe, Lawrence Kingsley, Donald R. Hoover, Joan S. Chmiel, Thomas Hammerstrom, Haihong Shi, Kimberly Struble, Jeremy M. G. Taylor, Steven G. Terra and Charles R. Rinaldo and has published in prestigious journals such as American Journal of Epidemiology, Environmental Health Perspectives and The Journal of Infectious Diseases.

In The Last Decade

Susan Zhou

28 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Zhou United States 16 294 210 145 114 91 28 581
Erez Battat Israel 11 187 0.6× 116 0.6× 169 1.2× 119 1.0× 134 1.5× 24 736
Claire Raskino United States 12 307 1.0× 365 1.7× 103 0.7× 40 0.4× 66 0.7× 19 713
Julie A. Predhomme United States 13 581 2.0× 272 1.3× 227 1.6× 36 0.3× 44 0.5× 17 749
Christine Hartman United States 15 219 0.7× 77 0.4× 185 1.3× 75 0.7× 53 0.6× 26 737
Marı́a José Galindo Spain 16 466 1.6× 302 1.4× 229 1.6× 30 0.3× 48 0.5× 66 789
Gregory Fusco United States 13 409 1.4× 257 1.2× 115 0.8× 44 0.4× 58 0.6× 57 614
Mohamed Janabi Tanzania 14 170 0.6× 58 0.3× 221 1.5× 73 0.6× 224 2.5× 55 864
Daniel Seekins United States 19 532 1.8× 324 1.5× 211 1.5× 41 0.4× 62 0.7× 30 746
Jacob Levi United Kingdom 12 538 1.8× 116 0.6× 267 1.8× 23 0.2× 39 0.4× 21 761
Amanda M. Farr United States 12 116 0.4× 35 0.2× 87 0.6× 66 0.6× 37 0.4× 36 441

Countries citing papers authored by Susan Zhou

Since Specialization
Citations

This map shows the geographic impact of Susan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Zhou more than expected).

Fields of papers citing papers by Susan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Zhou. The network helps show where Susan Zhou may publish in the future.

Co-authorship network of co-authors of Susan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Zhou. A scholar is included among the top collaborators of Susan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Zhou. Susan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nucci, Gianluca, Ernesto Callegari, Susan Zhou, et al.. (2021). End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor. CPT Pharmacometrics & Systems Pharmacology. 10(6). 529–542. 9 indexed citations
2.
Zhou, Susan, et al.. (2020). Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus. Clinical Pharmacology in Drug Development. 10(7). 696–706. 4 indexed citations
3.
Matschke, Kyle, Yali Liang, Hua Wei, et al.. (2019). Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components. Clinical Pharmacology in Drug Development. 8(7). 884–894. 4 indexed citations
4.
Liang, Yali, Haihong Shi, Anne Hickman, et al.. (2019). Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components. Clinical Pharmacology in Drug Development. 9(1). 50–61. 8 indexed citations
5.
Sahasrabudhe, Vaishali, Steven G. Terra, Anne Hickman, et al.. (2018). Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic Impairment. Clinical Therapeutics. 40(10). 1701–1710. 19 indexed citations
6.
Cutler, David L., Susan Zhou, Rajesh Krishna, et al.. (2018). Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects. Clinical Pharmacology in Drug Development. 8(3). 314–325. 22 indexed citations
7.
Soon, Guoxing, Min Min, Kimberly Struble, et al.. (2012). Meta-Analysis of Gender Differences in Efficacy Outcomes for HIV-Positive Subjects in Randomized Controlled Clinical Trials of Antiretroviral Therapy (2000–2008). AIDS Patient Care and STDs. 26(8). 444–453. 56 indexed citations
8.
Smith, F. M., Thomas Hammerstrom, Susan Zhou, et al.. (2011). A Meta-analysis to Assess the FDA DAVP’s TLOVR Algorithm in HIV Submissions. Drug Information Journal. 45(3). 291–300. 46 indexed citations
9.
Rotheram‐Borus, Mary Jane, Debra A. Murphy, Dallas Swendeman, et al.. (1999). Substance use and its relationship to depression, anxiety, and isolation among youth living with HIV. International Journal of Behavioral Medicine. 6(4). 293–311. 16 indexed citations
10.
Brown, Arthur E., John D. Malone, Susan Zhou, James R. Lane, & Clifton A. Hawkes. (1997). Human Immunodeficiency Virus RNA Levels in US Adults: A Comparison Based upon Race and Ethnicity. The Journal of Infectious Diseases. 176(3). 794–797. 19 indexed citations
11.
Brown, Arthur E., Maryanne Vahey, Susan Zhou, et al.. (1995). Quantitative Relationship of Circulating p24 Antigen with Human Immunodeficiency Virus (HIV) RNA and Specific Antibody in HIV-Infected Subjects Receiving Antiretroviral Therapy. The Journal of Infectious Diseases. 172(4). 1091–1094. 21 indexed citations
12.
Penkower, Lili, Mary Amanda Dew, Lawrence Kingsley, et al.. (1995). Alcohol consumption as a cofactor in the progression of HIV infection and AIDS. Alcohol. 12(6). 547–552. 22 indexed citations
13.
Brown, Arthur E., James R. Lane, Susan Zhou, et al.. (1995). Rates of p24 antigenemia and viral isolation in comparable white and black HIV-infected subjects. AIDS. 9(4). 325–328. 3 indexed citations
14.
Galai, Noya, et al.. (1993). Tracking of markers and onset of disease among HIV‐1 seroconverters. Statistics in Medicine. 12(22). 2133–2145. 33 indexed citations
15.
Zhou, Susan, Lawrence Kingsley, Jeremy M. G. Taylor, et al.. (1993). A method to test for a recent increase in HIV‐1 seroconversion incidence: Results from the multicenter AIDS cohort study (MACS). Statistics in Medicine. 12(2). 153–164. 5 indexed citations
16.
Ferbas, John, Lawrence Kingsley, John A. Armstrong, et al.. (1992). Frequent oropharyngeal shedding of Epstein-Barr virus in homosexual men during early HIV infection. AIDS. 6(11). 1273–1278. 20 indexed citations
17.
Hoover, Donald R., et al.. (1992). Effect of CD4+ Cell Count Measurement Variability on Staging HIV-1 Infection. PubMed. 5(8). 794???802–794???802. 71 indexed citations
18.
Zhou, Susan, et al.. (1991). Computations of adjusted rates and lifetime risks from occupational cohort data: A program package using FORTRAN and GLIM. Computers and Biomedical Research. 24(1). 29–46. 2 indexed citations
19.
Mazumdar, Sati, et al.. (1991). Recent Developments in the Multistage Modeling of Cohort Data for Carcinogenic Risk Assessment. Environmental Health Perspectives. 90. 271–271. 3 indexed citations
20.
Mazumdar, Sati, Carol Redmond, Philip E. Enterline, et al.. (1989). Multistage Modeling of Lung Cancer Mortality Among Arsenic‐Exposed Copper‐Smelter Workers. Risk Analysis. 9(4). 551–563. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erez Battat Breakdown of academic impact, for papers by Claire Raskino Breakdown of academic impact, for papers by Julie A. Predhomme Breakdown of academic impact, for papers by Christine Hartman Breakdown of academic impact, for papers by Marı́a José Galindo Breakdown of academic impact, for papers by Gregory Fusco Breakdown of academic impact, for papers by Mohamed Janabi Breakdown of academic impact, for papers by Daniel Seekins Breakdown of academic impact, for papers by Jacob Levi Breakdown of academic impact, for papers by Amanda M. Farr
Rankless by CCL
2026